RFI Deadline – Malaria Prophylactic Drug Tafenoquine
Global Biodefense CalendarThe U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick, MD, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. The operational testing will look at the drug’s performance attributes and usability. The DoD is seeking sources, capability statements, and industry feedback